Esperion

ESPR

Esperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

Insider trades and stock quote 2021/2020

All insider trades at Esperion

Subscribe RSS
DateTypeInsiderPositionØ-PriceVolume
11/3/2020 BuyBiotech, Target N V. Ten Percent Owner $25.3 $5,062,120
3/11/2020 BuyMayleben, Timothy M. President & CEO $43.0 $107,500
2/28/2020 BuyMayleben, Timothy M. President & CEO $49.0 $245,000
1/23/2020 BuyBiotech, Target N V. Ten Percent Owner $52.1 $1,042,398
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)

Free Updates via Email

Get a summary with the most interesting insider trades of the last weeks.
See data protection agreement.